Obama's deal with drug firms survives
Democratic senators tried unsuccessfully to override a deal the drug industry struck months ago with the Obama White House and Senate Finance Committee Chairman Max Baucus (D-Mont.). If the deal fell apart, industry allies warned, the drug lobby could pivot from health reform cheerleader to committed opponent armed with a $125 million war chest. It also foreshadowed battles to come as Democrats in both the House and Senate vowed anew to seek larger concessions from an industry that spent $92 million in lobbying in the first half of this year.
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Acute Kidney Injury Gets New Focus
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- mHealth Tackles Readmissions
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Sharp HealthCare Leaves Pioneer ACO Program
- MA an Insurance Proving Ground for Providers